LOGIN
Use of Tranexamic Acid for Adverse Events Post Posterior Fusion in Patients With Scoliosis
December 2024
Use of Tranexamic Acid for Adverse Events Post Posterior Fusion in Patients With Scoliosis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Evaluation of the use of tranexamic acid in the postoperative period in patients with scoliosis undergoing posterior fusion.
Neurosurg Rev . 2024 Aug 10;47(1):416.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Twenty-eight patients with scoliosis (21 idiopathic, 7 other etiologies) were randomized to receive tranexamic acid intraoperatively and postoperatively (n=14) or intraoperatively only (n=14). The primary outcome was postoperative blood loss measured through drain output. Secondary outcomes included transfusion requirements, length of hospital stay, and incidence of adverse effects. Outcomes were ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.